Publicaciones (25) Publicaciones de JAVIER FERNANDEZ MATEOS

2024

  1. Backtracking NOM1::ETV6 fusion to neonatal pathogenesis of t(7;12) (q36;p13) infant AML

    Leukemia

2023

  1. Contribution of pks+ E. coli mutations to colorectal carcinogenesis

    Nature Communications, Vol. 14, Núm. 1

2022

  1. Genetic susceptibility to telomere shortening through the rs2293607 polymorphism is associated with a greater risk of alcohol use disorder

    Mechanisms of ageing and development, Vol. 206, pp. 111693

  2. Phenotypic plasticity and genetic control in colorectal cancer evolution

    Nature, Vol. 611, Núm. 7937, pp. 744-753

  3. The co-evolution of the genome and epigenome in colorectal cancer

    Nature, Vol. 611, Núm. 7937, pp. 733-743

2021

  1. EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancers

    Gut, Vol. 70, Núm. 9, pp. 1632-1641

  2. Telomere length shortening associated with cataract in younger adults publica

    Revista Mexicana de Oftalmologia, Vol. 95, Núm. 1, pp. 1-7

2020

  1. Exploiting evolutionary steering to induce collateral drug sensitivity in cancer

    Nature Communications, Vol. 11, Núm. 1

  2. Measuring single cell divisions in human tissues from multi-region sequencing data

    Nature Communications, Vol. 11, Núm. 1

  3. Oncogenic driver mutations predict outcome in a cohort of head and neck squamous cell carcinoma (HNSCC) patients within a clinical trial

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Genetic susceptibility in head and neck squamous cell carcinoma in a spanish population

    Cancers, Vol. 11, Núm. 4

2018

  1. Biomarkers and polymorphisms in pancreatic neuroendocrine tumors treated with sunitinib

    Oncotarget, Vol. 9, Núm. 97, pp. 36894-36905

  2. Corrigendum: Association of VAV2 and VAV3 polymorphisms with cardiovascular risk factors

    Scientific reports

  3. Longitudinal liquid biopsy and mathematical modeling of clonal evolution forecast time to treatment failure in the prospect-c phase ii colorectal cancer clinical trial

    Cancer Discovery, Vol. 8, Núm. 10, pp. 1270-1285

  4. MIR21 Drives Resistance to Heat Shock Protein 90 Inhibition in Cholangiocarcinoma

    Gastroenterology, Vol. 154, Núm. 4, pp. 1066-1079.e5

  5. Patient-derived organoids model treatment response of metastatic gastrointestinal cancers

    Science, Vol. 359, Núm. 6378, pp. 920-926

2017

  1. A novel capillary nano-immunoassay for assessing androgen receptor splice variant 7 in plasma. Correlation with CD133 antigen expression in circulating tumor cells. A pilot study in prostate cancer patients

    Clinical and Translational Oncology, Vol. 19, Núm. 11, pp. 1350-1357

  2. Analysis of autophagy gene polymorphisms in Spanish patients with head and neck squamous cell carcinoma

    Scientific Reports, Vol. 7, Núm. 1

  3. Asociación de factores de riesgo ambientales en el desarrollo de las cataratas preseniles

    Revista Mexicana de Oftalmologia, Vol. 91, Núm. 2, pp. 56-61

  4. Association of VAV2 and VAV3 polymorphisms with cardiovascular risk factors

    Scientific Reports, Vol. 7